amikacin has been researched along with Kidney Diseases in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 66 (57.89) | 18.7374 |
1990's | 13 (11.40) | 18.2507 |
2000's | 13 (11.40) | 29.6817 |
2010's | 15 (13.16) | 24.3611 |
2020's | 7 (6.14) | 2.80 |
Authors | Studies |
---|---|
Ghaffari, S; Hadi, AM; Mojtahedzadeh, M; Najafi, A; Najmeddin, F; Rouini, MR; Shahrami, B | 1 |
Al Ansari, E; Al Jufairi, M; Al Madhoob, A; Al Marzooq, R; Al Segai, O; Hashem Ahmed, H; Husain Shaban, G; Malalla, Z; Saeed Tabbara, K; Sridharan, K | 1 |
Armagan, I; Bilgic, S; Ozer, MK; Savran, M | 1 |
Dvořáčková, E; Hojný, M; Kováčová, B; Pávek, P; Rychlíčková, J; Suchopár, O; Tebbens, JD; Vlček, J | 1 |
Burt, RA; Lockhart, PJ; Ogier, JM | 1 |
Azmy, A; El-Amir, A; Madbouly, N; Salama, A | 1 |
Çıkrıkçıoğlu, MA; Çoban, G; Doğan, EE; Döner, B; Ekinci, İ; Erkoç, R; Hamdard, J; Karatoprak, C; Kazancıoğlu, R; Özer, ÖF | 1 |
Choi, JE; Jeon, K; Jhun, BW; Kim, DH; Kim, SY; Ko, JY; Koh, WJ; Lee, H; Lee, SY; Moon, IJ; Park, HJ; Park, HY; Shin, SJ; Sohn, YM | 1 |
Abd El-Raouf, OM; Gad, AM; Khalaf, MM; Selim, A | 1 |
Kato, T; Nakayama, H; Suzuki, M; Usuki, K | 1 |
Admasu, A; Berha, AB; Negash, Z; Sheth, AN; Shibeshi, W; Yimer, G | 1 |
Calvo, MV; Lanao, JM; Martín-Suárez, A; Pérez-Blanco, JS; Sáez Fernández, EM | 1 |
Edwards, JD; Wargo, KA | 1 |
Dimic, ND; Milovanovic, DR; Mitrovic, SLj; Radovanovic, DM; Radovanovic, M; Vojinovic, RH | 1 |
Altuntas, I; Cetin, H; Kara, A; Kaya, S; Metin Ciris, I; Oktem, F | 1 |
Alp, HH; Ari, E; Basbugan, Y; Bayram, I; Bektas, H; Bulut, G; Erten, R | 1 |
Bookstaver, PB; Johnson, JW; McCoy, TP; Stewart, D; Williamson, JC | 1 |
Asci, H; Bayram, D; Cicek, E; Oncu, M; Ozer, MK; Savran, M; Yesilot, S | 1 |
Asgharzadeh-Haghighi, S; Ghasemi, A; Ghazi-Khansari, M; Jabari, E; Mohammadi-Karakani, A; Seyed-Ebrahimi, A | 1 |
Sweileh, WM | 2 |
Corkery, K; Eldon, MA; Gribben, D; Stass, H | 1 |
Bompolaki, I; Bozionelou, V; Falagas, ME; Kalpadaki, C; Karageorgopoulos, DE; Koutsounaki, E; Mitsikostas, P; Samonis, G; Sgouros, J; Taktikou, V | 1 |
Al, S; Alkanat, M; Ersoz, S; Kaynar, K; Orem, A; Ozkan, G; Ulusoy, S; Yucesan, FB | 1 |
Beytur, A; Cinar, K; Dogan, Z; Ekinci, N; Ekincioglu, Z; Kose, E; Soysal, H; Turkoz, Y; Vardi, N | 1 |
Claude, D; Corvaisier, S; Ducher, M; Jelliffe, R; Maire, P; Maurin, M; Rougier, F; Sedoglavic, A | 1 |
Alkan, M; Almog, Y; Bartal, C; Danon, A; Reisenberg, K; Schlaeffer, F; Sidi, A; Smoliakov, R | 1 |
Claude, D; Corvaisier, S; Ducher, M; Jelliffe, R; Maire, P; Maurin, M; Rougier, F | 1 |
Claude, D; Corvaisier, S; Ducher, M; Jelliffe, RW; Maire, P; Rougier, F | 1 |
Acet, A; Koc, M; Ozer, MK; Parlakpinar, H; Polat, A; Turkoz, Y; Vardi, N | 1 |
Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
Charrel, CT; François, G; Gouin, F; Granthil, C; Martin, C; Savin, B | 1 |
Alazia, M; Dubouloz, F; Granthil, C | 1 |
Good, F; Harding, E; Klein, J; MacLeod, S; Perlman, M; Prober, CG; Rajchgot, P; Soldin, S | 1 |
Bhandari, JC; Donikian, MR; Drobeck, HP; Fabian, RJ; Montenaro, MJ; Slighter, RG | 1 |
Dickson, JA; Duerden, BI; Milner, RD; Salfield, SA | 1 |
Bhend, H; Blaser, J; Lüthy, R; Rüttimann, S | 1 |
Dominguez-Gil, A; Gonzalez Lopez, A; Lanao, JM; Navarro, AS; Rodriguez, IC; Tabernero, JM | 1 |
Aso, Y; Fujita, HM; Fujita, K | 1 |
Fieren, MW; Goessens, WH; Michel, MF; Wagenvoort, JH | 1 |
Barge, J; Brion, N; Carbon, C; Contrepois, A; Dromer, F; Dubois, C; Godefroy, I | 1 |
Lietman, PS; Moore, RD; Smith, CR | 1 |
Bauer, LA; Blouin, RA | 1 |
Ho, PW; Pien, FD | 1 |
Meyer, RD | 1 |
Deshpande, G; Faden, H; Grossi, M | 1 |
Dominguez-Gil, A; Lanao, JM; Molina, HD; Tabernero, JM | 1 |
Assael, BM; Cavanna, G; Cornacchia, L; Parini, R; Rusconi, F; Vigliani, E | 1 |
Hallynck, T; Pijck, J; Soep, H | 1 |
Bennett, WM; DeFehr, J; Gilbert, DN; Houghton, DC; Kohlhepp, SJ; Plamp, CE; Porter, GA; Webb, M | 1 |
Crespo, M; Dominguez-Gil, A; Dominguez-Gil, AA; Lanao, JM; Málaga, S; Santos, F | 1 |
Sawae, Y; Takii, M | 1 |
Battisti, O; Bernard, A; Bertrand, JM; Buchet, JP; Darimont, J; François, A; Ibrahim, S; Langhendries, JP; Scalais, E; Tulkens, PM | 1 |
Bao, ZD; Wu, ZG; Zheng, F | 1 |
Goetz, MB; Sayers, J | 1 |
Alós-Almiñana, M; Ferriols-Lisart, R | 1 |
Bahnassy, AA; Eltahawy, AT | 1 |
Andronikou, S; Cholevas, VI; Giapros, VI; Papadopoulou, ZL | 1 |
Casassus, P; Guillevin, L; Lortholary, O; Petitjean, O; Semaoun, R; Seytre, D; Tod, M; Uzzan, B | 1 |
Georgiou, A; Halkiadaki, D; Houpas, P; Karachalios, GN; Karachaliou, I; Papalimneou, V; Tziviskou, E | 1 |
Hite, Y; Kopyt, M; Raveh, D; Rudensky, B; Sonnenblick, M; Yinnon, AM | 1 |
de Jager, P; van Altena, R | 1 |
Eikenberg, P; Sack, K; Züllich, B | 1 |
Edwards, CQ; Lietman, PS; Maxwell, RR; Rogers, JF; Smith, CR | 1 |
Appel, GB; Neu, HC | 1 |
Gioannini, P | 1 |
De Castro, S; Domínguez-Gil, A; Lanao, JM; Tabernero, JM | 1 |
Lietman, PS; Lipsky, JJ; Smith, CR | 1 |
Fabre, J; Rudhardt, M | 1 |
Dinwiddie, CB; Isaacs, LL; Luft, FC; Rankin, LI; Sloan, RS; Yum, MN | 1 |
Came, PE; Dobson, RA; Fabian, RJ; O'Connor, JR; Wagner, RB | 1 |
Sack, K; Züllich, B | 1 |
Black, RE; Hewitt, WL; Lau, WK; Linne, SR; Weinstein, RJ; Winston, DJ; Young, LS | 1 |
Hull, JH; Sarubbi, FA | 1 |
Anttila, M; Kangas, L; Kasanen, A; Nieminen, L; Sairio, E | 1 |
Bodey, GP; Keating, MJ; Samaan, NA; Sethi, MR | 1 |
Blair, DC; Lane, AZ; Wright, GE | 1 |
Finegold, SM; Lewis, RP; Meyer, RD | 1 |
Seneca, H | 1 |
Demers, HG; Höffler, D; Koeppe, P | 1 |
Federspil, P | 1 |
Klastensky, J; Levy, J | 1 |
Akutsu, S; Matsuzaki, M; Mukogawa, H; Shimamura, T | 1 |
Akutsu, S; Matsuzaki, M; Onodera, K; Sekino, M; Yoshida, A | 1 |
Hirth, RS | 1 |
Klein, J; Koren, G; MacLeod, SM | 1 |
Mueller, R; Suzuki, CA; Thomas, BH | 1 |
Goto, M; Iwayama, N; Izuhara, Y; Kusafuka, H; Maeda, K; Obayashi, T; Sezaki, R; Yoshida, H | 1 |
Kobilski, S; Lipman, J; Marik, PE; Scribante, J | 1 |
Baker, DK; Goren, MP; Shenep, JL | 1 |
Casner, P; Dillon, KR; Dougherty, SH; Polly, S | 1 |
Bobadilla, J; Contreras, AM; Cortés, J; Espinosa, A; Gamba, G; Jimenez-Sanchez, G; López, G; Nares, F; Santiago, Y; Valadez, A | 1 |
Inouye, S; Kitasato, I; Niizato, T; Shomura, T | 1 |
Cambar, J; Catroux, P; Dorian, C | 2 |
Fillastre, JP; Morin, JP; Olier, B; Thomas, N | 1 |
Bailie, GR; Mathews, A | 1 |
Armstrong, DK; Dasta, JF; Garner, WL; Hodgman, T; Reilley, TE; Visconti, JA | 1 |
Inouye, S; Kurebe, M; Omoto, S; Yoshida, T | 1 |
Alexopoulos, E; Anassis, P; Hadjidimitriou, C; Papadimitriou, M | 1 |
Arroyo, JC; Davis, J; Milligan, WL; Mitchell, D | 1 |
De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW | 1 |
Buchanan, N | 1 |
Chen, HJ; Guh, JY; Su, YH; Tsai, JH | 1 |
Zinner, SH | 1 |
Araujo, V; Ballesta, A; Castells, C; Elena, M; Gatell, JM; Jimenez de Anta, MT; Marin, JL; Moreno, A; SanMiguel, JG; Zamora, L | 1 |
Carson, CC; Paulson, DF; Rudd, C | 1 |
Hull, JH; Rogers, JF; Sarubbi, FA; Wargin, WA; Williams, PJ | 1 |
Fujita, HM; Fujita, K | 1 |
Gong, Z; Gu, D; Han, Y; He, D; Ren, H; Shi, Y; Xia, T; Yang, J; Zeng, C | 1 |
Li, Y; Ruan, C; Song, B; Xue, W; Zhao, J | 1 |
9 review(s) available for amikacin and Kidney Diseases
Article | Year |
---|---|
Aminoglycoside-induced nephrotoxicity.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Kidney Diseases; Tobramycin | 2014 |
Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.
Topics: Amikacin; Bacteria; Drug Resistance, Microbial; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Kinetics; Neuromuscular Junction | 1981 |
Amikacin.
Topics: Amikacin; Ear Diseases; Humans; Kanamycin; Kidney Diseases; Kinetics | 1981 |
Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination.
Topics: Aged; Aged, 80 and over; Amikacin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Vancomycin | 1993 |
Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Drug Administration Schedule; Ear Diseases; Gentamicins; Humans; Infections; Kidney Diseases; Middle Aged; Netilmicin | 1996 |
Gentamicin in 1978.
Topics: Amikacin; Animals; Bacterial Infections; Drug Synergism; Ear Diseases; Gentamicins; Humans; Kidney; Kidney Diseases; Netilmicin; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Sisomicin; Tobramycin; Urinary Tract Infections | 1978 |
[Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kanamycin; Kidney Diseases; Kidney Function Tests; Sisomicin; Streptomycin; Tobramycin | 1978 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.
Topics: Amikacin; Aminoglycosides; Cost-Benefit Analysis; Ear Diseases; Gentamicins; Humans; Kidney Diseases; Netilmicin; Tobramycin | 1987 |
21 trial(s) available for amikacin and Kidney Diseases
Article | Year |
---|---|
A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Young Adult | 2009 |
Pharmacokinetics and tolerability of BAY41-6551 in subjects with chronic kidney disease.
Topics: Adult; Aerosols; Aged; Amikacin; Anti-Bacterial Agents; Area Under Curve; Chronic Disease; Drug Delivery Systems; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Severity of Illness Index; Time Factors | 2011 |
Pharmacokinetic dosing of aminoglycosides: a controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Endpoint Determination; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Single-Blind Method; Treatment Outcome | 2003 |
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Cefazolin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Kanamycin; Kidney Diseases; Neoplasms; Neutropenia | 1983 |
Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity.
Topics: Amikacin; Creatinine; Enzymes; Evoked Potentials, Auditory, Brain Stem; Female; Glomerular Filtration Rate; Hearing Disorders; Humans; Infant, Newborn; Kidney Diseases; Male; Phospholipids; Pilot Projects; Proteinuria | 1993 |
[Amelioration of aminoglycoside nephrotoxicity by Cordyceps sinensis in old patients].
Topics: Acetylglucosaminidase; Aged; Amikacin; Animals; beta 2-Microglobulin; Bronchitis; Drugs, Chinese Herbal; Female; Humans; Hypocreales; Kidney; Kidney Diseases; Male; Middle Aged; Moths; Pneumonia | 1994 |
Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the Eu
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ear Diseases; Female; Humans; Infant, Newborn; Infections; Kidney Diseases; Male; Middle Aged; Neoplasms; Prospective Studies; Treatment Outcome | 1993 |
Effect of aminoglycoside therapy on renal function in full-term infants.
Topics: Amikacin; Anti-Bacterial Agents; Gentamicins; Humans; Infant, Newborn; Kidney Diseases; Kidney Function Tests; Netilmicin; Time Factors; Water-Electrolyte Imbalance | 1996 |
Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Enzyme-Linked Immunosorbent Assay; Female; Fever; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Neutropenia; Population | 1998 |
Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Female; Hearing Disorders; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies | 1998 |
Nephrotoxicity induced by gentamicin and amikacin.
Topics: Adult; Aged; Amikacin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gentamicins; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Prospective Studies | 1978 |
Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalothin; Drug Therapy, Combination; Gentamicins; Hearing Disorders; Humans; Kidney Diseases; Middle Aged; Tobramycin | 1979 |
Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.
Topics: Adult; Amikacin; Bacterial Infections; Carbenicillin; Drug Synergism; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Leukopenia; Penicillin Resistance; Sepsis | 1977 |
Correlation of serum creatinine concentration and amikacin half-life.
Topics: Adult; Amikacin; Clinical Trials as Topic; Creatinine; Half-Life; Humans; Kanamycin; Kidney Diseases | 1975 |
A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients.
Topics: Adolescent; Adult; Amikacin; Creatinine; Critical Care; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Kidney Diseases; Male; Middle Aged; Prospective Studies | 1991 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Individualized pharmacokinetic versus standard dosing of amikacin: a comparison of therapeutic outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Drug Resistance, Microbial; Female; Humans; Kidney Diseases; Male; Middle Aged; Randomized Controlled Trials as Topic | 1989 |
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation | 1986 |
Review of amikacin usage in the EORTC trials.
Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Gentamicins; Humans; International Cooperation; Kanamycin; Kidney Diseases; Lactams; Neoplasms; Neutropenia | 1985 |
Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
Topics: Adult; Aged; Amikacin; beta 2-Microglobulin; Clinical Trials as Topic; Creatinine; Humans; Kanamycin; Kidney Diseases; Middle Aged; Prospective Studies; Random Allocation; Tobramycin | 1985 |
85 other study(ies) available for amikacin and Kidney Diseases
Article | Year |
---|---|
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Critical Illness; Half-Life; Humans; Kidney Diseases; Middle Aged | 2022 |
Biomarkers in neonates receiving potential nephrotoxic drugs.
Topics: Acetaminophen; Adult; Amikacin; Biomarkers; Cystatins; Female; Furosemide; Gentamicins; Hepatitis A Virus Cellular Receptor 1; Humans; Ibuprofen; Infant, Newborn; Kidney Diseases; Lipocalin-2; Male; Middle Aged; Vancomycin | 2021 |
Thymoquinone protection from amikacin induced renal injury in rats.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Benzoquinones; Creatinine; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley | 2020 |
Is computer-assisted aminoglycoside dosing managed by a pharmacist a safety tool of pharmacotherapy?
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Costs and Cost Analysis; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Computer-Assisted; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Pharmacists; Pilot Projects; Prospective Studies; Safety; Treatment Outcome | 2019 |
Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Administration Schedule; Hearing; Hearing Loss; Injections, Intravenous; Kidney; Kidney Diseases; Mice, Inbred C57BL; Ototoxicity; Species Specificity; Time Factors; Tobramycin | 2020 |
The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Apoptosis; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Fibrosis; HSP27 Heat-Shock Proteins; Inflammation; Kidney Diseases; Male; Monocytes; Rats; Rats, Sprague-Dawley; Taurine; Toll-Like Receptor 4; Uric Acid | 2021 |
Protective effect of dexpanthenol against nephrotoxic effect of amikacin: An experimental study.
Topics: Amikacin; Animals; Antioxidants; Edema; Epithelium; Female; Kidney; Kidney Diseases; Oxidants; Oxidative Stress; Pantothenic Acid; Protective Agents; Rats; Rats, Wistar | 2017 |
Once-daily dosing of amikacin for treatment of
Topics: Aged; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Female; Hearing Loss; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Republic of Korea; Retrospective Studies; Tinnitus | 2017 |
Evaluation of the possible nephroprotective effects of vitamin E and rosuvastatin in amikacin-induced renal injury in rats.
Topics: Amikacin; Animals; Biomarkers; Drug Therapy, Combination; Kidney; Kidney Diseases; Male; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley; Rosuvastatin Calcium; Vitamin E | 2017 |
Amikacin Pharmacokinetics in Terminal Stage of Hematological Malignancy.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Disease Progression; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Young Adult | 2019 |
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Creatinine; Ethiopia; Female; HIV Infections; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
Evaluation of renal function equations to predict amikacin clearance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Retrospective Studies; Tissue Distribution; Young Adult | 2019 |
Hepatic abscess originating from renal suppurative collection.
Topics: Abdominal Pain; Abscess; Adult; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Humans; Kidney Diseases; Liver Abscess; Male; Multidetector Computed Tomography; Treatment Outcome | 2015 |
Amikacin induced renal damage and the role of the antioxidants on neonatal rats.
Topics: Amikacin; Animals; Animals, Newborn; Anti-Bacterial Agents; Antioxidants; Disease Models, Animal; Erythropoietin; Kidney Diseases; Kidney Function Tests; Malondialdehyde; Nitric Oxide; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Treatment Outcome; Vitamin E | 2016 |
Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Amikacin; Animals; Anti-Bacterial Agents; Bone Density Conservation Agents; Deoxyguanosine; Disease Models, Animal; DNA Damage; Ergocalciferols; Kidney; Kidney Diseases; Kidney Function Tests; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2016 |
Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Body Surface Area; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Forecasting; Gentamicins; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Tobramycin | 2008 |
Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Creatinine; Free Radical Scavengers; Kidney; Kidney Diseases; Male; Malondialdehyde; Pentoxifylline; Rats; Rats, Wistar | 2009 |
Enzymuria determination in children treated with aminoglycosides drugs.
Topics: Acetylglucosaminidase; Albuminuria; Alkaline Phosphatase; Amikacin; Anti-Bacterial Agents; Biomarkers; Child, Preschool; Clinical Enzyme Tests; Creatinine; Female; Gentamicins; Humans; Infant; Kidney Diseases; L-Lactate Dehydrogenase; Male; Predictive Value of Tests; Time Factors; Up-Regulation; Urea | 2008 |
Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Biomarkers; Creatinine; Female; Gentamicins; Humans; Inpatients; Kidney Diseases; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Time Factors; Up-Regulation; Young Adult | 2009 |
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Kidney Diseases; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Survival Analysis; Treatment Outcome | 2012 |
The effect of grape seed proanthocyanidin extract in preventing amikacin-induced nephropathy.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Grape Seed Extract; Kidney Diseases; Phytotherapy; Proanthocyanidins; Rats; Rats, Sprague-Dawley | 2012 |
The effects of montelukast against amikacin-induced acute renal damage.
Topics: Acetates; Acute Disease; Amikacin; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blood Urea Nitrogen; Creatinine; Cyclopropanes; Cytoprotection; Disease Models, Animal; Female; Glutathione; Immunohistochemistry; Interleukin-1beta; Kidney; Kidney Diseases; Malondialdehyde; Peroxidase; Quinolines; Rats; Rats, Wistar; Sulfides; Tumor Necrosis Factor-alpha | 2012 |
Aminoglycoside nephrotoxicity: modeling, simulation, and control.
Topics: Adult; Algorithms; Amikacin; Anti-Bacterial Agents; Area Under Curve; Circadian Rhythm; Computer Simulation; Creatinine; Female; Humans; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Male; Models, Biological; Vancomycin | 2003 |
Aminoglycoside dosages and nephrotoxicity: quantitative relationships.
Topics: Amikacin; Anti-Bacterial Agents; Area Under Curve; Creatinine; Drug Administration Schedule; Humans; Kidney Diseases; Retrospective Studies | 2003 |
[PK/PD modeling of aminoglycoside nephrotoxicity].
Topics: Amikacin; Anti-Bacterial Agents; Biomarkers; Chronotherapy; Creatinine; Endocarditis, Bacterial; Feedback, Physiological; Glomerular Filtration Rate; Humans; Kidney Cortex; Kidney Diseases; Kidney Tubules; Models, Biological | 2003 |
Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats.
Topics: Amikacin; Analysis of Variance; Animals; Biopsy, Needle; Disease Models, Animal; Drug Interactions; Female; Guanidines; Immunohistochemistry; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Malondialdehyde; Probability; Protective Agents; Random Allocation; Rats; Rats, Wistar; Sensitivity and Specificity | 2004 |
[Serial measurement of serum levels of amikacin. Value in therapy].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Female; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Time Factors | 1981 |
[Spacing doses of amikacin in renal failure patients. Calculation based on blood creatinine expressed in micromoles].
Topics: Amikacin; Creatinine; Humans; Kanamycin; Kidney Diseases; Osmolar Concentration | 1983 |
Aminoglycoside-related nephrotoxicity in the premature newborn.
Topics: Acetylglucosaminidase; Amikacin; beta 2-Microglobulin; Chloramphenicol; Creatinine; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Kanamycin; Kidney Diseases; Prospective Studies; Random Allocation; Sepsis | 1984 |
Comparative nephrotoxicity of hydroxygentamicin and other aminoglycosides in rats.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Body Weight; Creatinine; Gentamicins; Kidney Diseases; Kidney Function Tests; Male; Netilmicin; Organ Size; Rats; Rats, Inbred F344 | 1984 |
Abdominal nocardiosis in a Sudanese girl.
Topics: Abscess; Amikacin; Child; Drainage; Drug Combinations; Female; Humans; Kidney Diseases; Liver Abscess; Nocardia Infections; Sulfamethazine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Increase of amikacin half-life during therapy in patients with renal insufficiency.
Topics: Adult; Amikacin; Creatinine; Female; Half-Life; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged | 1983 |
Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment.
Topics: Adolescent; Adult; Amikacin; Blister; Exudates and Transudates; Humans; Kanamycin; Kidney Diseases; Kinetics; Middle Aged; Skin Absorption | 1983 |
[Protective effect of fosfomycin against renal accumulation of aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Fosfomycin; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred Strains | 1983 |
Clinical application of amikacin dosage based upon lean body mass in patients with different renal function.
Topics: Adolescent; Adult; Aged; Amikacin; Anthropometry; Creatinine; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Kanamycin; Kidney Diseases; Kinetics; Male; Middle Aged | 1984 |
Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Blood Proteins; Dibekacin; Gentamicins; Kidney Diseases; Kidney Tubules; Male; Netilmicin; Protein Binding; Rabbits | 1984 |
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
Topics: Adult; Aged; Amikacin; Body Temperature; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Kidney Diseases; Leukocyte Count; Middle Aged; Proteus Infections; Sepsis; Statistics as Topic; Tobramycin | 1984 |
Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
Topics: Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Creatinine; Female; Gentamicins; Humans; Kanamycin; Kidney Diseases; Kinetics; Male; Middle Aged; Tobramycin | 1983 |
Renal and Auditory toxic effects of amikacin in children with cancer.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Hearing Loss; Hearing Loss, High-Frequency; Humans; Infant; Kanamycin; Kidney Diseases; Neoplasms | 1982 |
Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
Topics: Adult; Aged; Amikacin; Creatinine; Humans; Injections, Intramuscular; Kanamycin; Kidney Diseases; Kinetics; Middle Aged | 1982 |
Evaluation of the renal and auditory function of neonates treated with amikacin.
Topics: Acetylglucosaminidase; Aging; Amikacin; Audiometry, Evoked Response; Behavior; Creatinine; Hearing Disorders; Hearing Tests; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Kidney Diseases; Kidney Function Tests | 1982 |
Influence of age and lean body mass on the relation of creatinine clearance and drug half-life.
Topics: Adolescent; Aging; Amikacin; Body Weight; Child; Child, Preschool; Creatinine; Female; Gentamicins; Half-Life; Humans; Infant; Infant, Newborn; Kidney Diseases; Liver; Male; Pharmaceutical Preparations | 1982 |
Amikacin nephrotoxicity in the rat.
Topics: Amikacin; Animals; Blood Urea Nitrogen; Creatinine; Kanamycin; Kidney Diseases; Male; Rats | 1980 |
Pharmacokinetics of amikacin in children with normal and impaired renal function.
Topics: Amikacin; Child; Child, Preschool; Female; Humans; Kanamycin; Kidney Diseases; Kinetics; Male | 1981 |
[Blood level of amikacin after drip intravenous infusion (author's transl)].
Topics: Adult; Aged; Amikacin; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Kanamycin; Kidney Diseases; Kinetics; Male; Time Factors | 1980 |
Gentamicin vs. tobramycin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Costs and Cost Analysis; Dogs; Gentamicins; Humans; Kidney Diseases; Tobramycin | 1980 |
Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a university hospital in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Gentamicins; Hospitals, University; Humans; Infant; Infant, Newborn; Kidney Diseases; Male; Middle Aged; Monitoring, Physiologic; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Saudi Arabia; Statistics as Topic; Treatment Outcome | 1996 |
Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Creatinine; Drug Administration Schedule; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Risk Factors | 2002 |
Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Audiometry; Child; Creatinine; Female; Hearing Loss, Bilateral; Humans; Kanamycin; Kidney; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2002 |
[Comparative studies on the problem of nephrotoxicity of the aminoglycosides: kanamycin, amikacin, butirosin and kanendomycin].
Topics: Amikacin; Animals; Anti-Bacterial Agents; Butirosin Sulfate; Female; Kanamycin; Kidney Diseases; Rats | 1976 |
Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
Topics: Adolescent; Adult; Aged; Amikacin; Female; Half-Life; Humans; Kanamycin; Kidney Diseases; Kidney Function Tests; Kinetics; Male; Middle Aged; Models, Biological | 1979 |
Behavior of amikacin in renal parenchyma of normal rats and of rats with acute obstructive renal insufficiency.
Topics: Amikacin; Animals; Half-Life; Kanamycin; Kidney Cortex; Kidney Diseases; Kinetics; Rats | 1979 |
Comparative nephrotoxicity of SCH 21420 and amikacin in rats.
Topics: Amikacin; Animals; Creatinine; Enzymes; Gentamicins; Kanamycin; Kidney Diseases; Male; Proteinuria; Rats; Time Factors | 1979 |
Antibacterial activities, nephrotoxicity, and ototoxicity of a new aminoglycoside, Win 42122-2.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Ataxia; Bacteria; Cats; Gentamicins; Guinea Pigs; Hearing Disorders; Kidney Diseases; Rats | 1979 |
[Amikacin and kanamycin. Comparative experimental studies on nephrotoxicity].
Topics: Amikacin; Animals; Blood Urea Nitrogen; Enzymes; Female; Glycosuria; Kanamycin; Kidney Diseases; Proteinuria; Rats; Time Factors | 1978 |
Amikacin serum concentrations: prediction of levels and dosage guidelines.
Topics: Adult; Amikacin; Body Weight; Computers; Creatinine; Humans; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Kidney Diseases; Mathematics | 1978 |
Renal accumulation of amikacin, tobramycin and gentamycin in the rat.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Gentamicins; Kanamycin; Kidney; Kidney Diseases; Rats; Solubility; Tobramycin | 1978 |
Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Doxorubicin; Female; Gentamicins; Humans; Hypocalcemia; Hypoparathyroidism; Kidney Diseases; Kidney Tubules; Leukemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone; Phosphates; Sisomicin; Syndrome; Tobramycin | 1977 |
Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States.
Topics: Adult; Aged; Amikacin; Audiometry; Child; Creatinine; Ear; Hearing Disorders; Humans; Kanamycin; Kidney; Kidney Diseases; Middle Aged; United States; Vestibulocochlear Nerve | 1977 |
Amikacin therapy for gram-negative septicemia.
Topics: Adult; Aged; Amikacin; Creatinine; Drug Resistance, Microbial; Female; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Sepsis | 1977 |
Gram-negative sepsis: part II. Management.
Topics: Acidosis; Adult; Amikacin; Child; Chloramphenicol; Clindamycin; Disseminated Intravascular Coagulation; Dopamine; Gentamicins; Heart Failure; Humans; Isoproterenol; Kanamycin; Kidney Diseases; Metaraminol; Phenoxybenzamine; Respiratory Insufficiency; Sepsis; Tobramycin | 1977 |
Pharmacokinetics of amikacin for treatment of urinary tract infections in patients with reduced renal function.
Topics: Aged; Amikacin; Chronic Disease; Drug Evaluation; Glomerular Filtration Rate; Half-Life; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Urinary Tract Infections | 1976 |
[Ototoxicity of the aminoglycoside antibiotics (author's transl)].
Topics: Acid Phosphatase; Alkaline Phosphatase; Amikacin; Animals; Anti-Bacterial Agents; Child; Ear, Inner; Esterases; Ethacrynic Acid; Gentamicins; Guinea Pigs; Humans; Kidney Diseases; Noise; Otitis Media; Sisomicin; Sulfhydryl Compounds; Tobramycin | 1976 |
[Teratological studies of amikacin (BB-K8) in mice and rats (author's transl)].
Topics: Abnormalities, Drug-Induced; Amikacin; Animals; Animals, Newborn; Body Weight; Drinking; Feeding Behavior; Female; Fetus; Growth; Injections, Intradermal; Kanamycin; Kidney Diseases; Mice; Osteogenesis; Pregnancy; Rats | 1975 |
[Studies on the toxicity of amikacin (BB-K8),III. Subacute toxicity of amikacin (BB-K8) in dogs (author's transl)].
Topics: Acute Disease; Amikacin; Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Dilatation, Pathologic; Dogs; Drinking; Drug Evaluation, Preclinical; Feeding Behavior; Female; Injections, Intramuscular; Kanamycin; Kidney Diseases; Kidney Tubules; Male; Sex Factors | 1975 |
Nephrotoxicity of amikacin (BB-K8), an aminoglycoside antibiotic.
Topics: Amikacin; Animals; Dogs; Kanamycin; Kidney; Kidney Diseases; Rats; Saimiri | 1975 |
Comparison of methods for prediction of nephrotoxicity during development.
Topics: Aging; Amikacin; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Gentamicins; Kidney; Kidney Diseases; Male; Predictive Value of Tests; Pregnancy; Rats; Rats, Wistar; Sensitivity and Specificity | 1992 |
Evaluation of enzymuria as an indicator of amikacin-induced renal damage in guinea pigs.
Topics: Acetylglucosaminidase; Alkaline Phosphatase; Amikacin; Animals; Biological Transport; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Guinea Pigs; Kidney Cortex; Kidney Diseases; Male; Quaternary Ammonium Compounds; Time Factors | 1992 |
[Protective effect by piperacillin against renal impairment caused by amikacin].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Middle Aged; Piperacillin | 1992 |
Serial trough and peak amikacin levels in plasma as predictors of nephrotoxicity.
Topics: Acute Kidney Injury; Aged; Amikacin; Humans; Kidney Diseases; Kidney Function Tests; Middle Aged | 1989 |
Nephrotoxicity of dactimicin, a novel pseudo-disaccharide aminoglycoside possessing the N-formimidoyl group, compared with that of astromicin, amikacin and other aminoglycoside antibiotics in animals.
Topics: Acetylglucosamine; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Creatinine; Kidney; Kidney Diseases; L-Lactate Dehydrogenase; Male; Mice; Organ Size; Osmolar Concentration; Proteinuria; Rats; Urodynamics | 1989 |
[Demonstration of seasonal changes of circadian rhythms of amikacin chrononephrotoxicity in rats].
Topics: Acetylglucosaminidase; Amikacin; Animals; Chronobiology Phenomena; Circadian Rhythm; Clinical Enzyme Tests; gamma-Glutamyltransferase; Hexosaminidases; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred Strains; Seasons | 1987 |
[Chrononephrotoxicity of amikacin after 7-day chronic poisoning in rats].
Topics: Acetylglucosaminidase; Alkaline Phosphatase; Amikacin; Animals; Chronobiology Phenomena; Clinical Enzyme Tests; gamma-Glutamyltransferase; Injections, Intramuscular; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred Strains; Time Factors | 1987 |
[Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Female; Gentamicins; Kanamycin; Kidney Cortex; Kidney Diseases; Netilmicin; Rats; Rats, Inbred Strains | 1988 |
Hemodialysis of amikacin in critically ill patients.
Topics: Adult; Aged; Amikacin; Critical Care; Female; Humans; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Renal Dialysis | 1988 |
Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Female; Guinea Pigs; Hearing Disorders; Kidney Diseases; Male; Mice; Microbial Sensitivity Tests; Rats | 1987 |
The efficacy of amikacin in the treatment of severe infections in a renal unit.
Topics: Amikacin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Hospital Units; Humans; Kidney Diseases; Male; Middle Aged; Penicillins; Sepsis | 1987 |
Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Costs and Cost Analysis; Creatinine; Decision Making; Evaluation Studies as Topic; Gentamicins; Humans; Immunoenzyme Techniques; Kidney Diseases; Middle Aged; Prognosis; Time Factors; Tobramycin | 1986 |
Aminoglycoside monitoring in neonates--a re-appraisal.
Topics: Amikacin; Aminoglycosides; Gentamicins; Humans; Infant, Newborn; Kidney Diseases; Labyrinth Diseases; Monitoring, Physiologic | 1985 |
The predictive value of urinary N-acetyl-beta-D-glucosaminidase in evaluating aminoglycoside nephrotoxicity.
Topics: Acetylglucosaminidase; Adult; Aged; Amikacin; Aminoglycosides; Female; Gentamicins; Hexosaminidases; Humans; Kanamycin; Kidney; Kidney Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged | 1985 |
Overview of first-line amikacin therapy for urologic infections.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Kidney Diseases; Lactams; Sepsis; Urinary Tract Infections | 1985 |
Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Creatinine; Female; Humans; Kanamycin; Kidney Diseases; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged | 1986 |
Comparative study on renal accumulation of aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Gentamicins; Half-Life; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred Strains; Streptomycin | 1985 |
AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Urea Nitrogen; Cell Adhesion Molecules; Cell Line; Contrast Media; Creatinine; Disease Models, Animal; Inflammation; Iohexol; Kidney Diseases; Lactate Dehydrogenases; Male; Oxidative Stress; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction | 2020 |
AdipoRon Attenuates Hypertension-Induced Epithelial-Mesenchymal Transition and Renal Fibrosis via Promoting Epithelial Autophagy.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Cell Line; Disease Models, Animal; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Hypertension; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Mice, Inbred C57BL; Phosphorylation; Piperidines | 2021 |